G

R

GERVAIS , Radj

Last name: GERVAIS

First name: Radj

August 2021 (v1)

Journal article

Metadata-only

First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50%

Descourt, Renaud Chouaid, Christos Pérol, Maurice

Pembrolizumab plus chemotherapy is currently used in the first-line treatment of advanced non-small-cell lung cancer without EGFR mutations or ALK rearrangements, regardless of PD-L1 expression status. A study comparing chemotherapy plus pembrolizumab versus pembrolizumab alone has never been performed in patients with PD-L1 ≥50%. The aim of...

Uploaded on: April 5, 2025